MTHFR and endothelial dysfunction: Polymorphisms in methylenetetrahydrofolate reductase (MTHFR) genes result in hyperhomocysteinemia, a known risk factor for vascular damage, endothelial dysfunction, and oxidative stress found in VaD and small vessel disease patients [59].